We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Expression Analysis Enters into a Partnership with Complement Genomics to Offer Genomic Services in UK
News

Expression Analysis Enters into a Partnership with Complement Genomics to Offer Genomic Services in UK

Expression Analysis Enters into a Partnership with Complement Genomics to Offer Genomic Services in UK
News

Expression Analysis Enters into a Partnership with Complement Genomics to Offer Genomic Services in UK

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Expression Analysis Enters into a Partnership with Complement Genomics to Offer Genomic Services in UK"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Expression Analysis enters into a partnership with Sunderland based Complement Genomics Ltd. to offer its genomic services to the UK market.

Expression Analysis, Inc. has entered into a partnership with Sunderland based Complement Genomics Ltd. to offer its genomic services to the UK market. By partnering with an established company, Expression Analysis will gain access to clients beyond its primary market in the US.

The Geneblitz® unit offers molecular services to pharmaceutical companies, governmental agencies, universities and research institutes. The partnership will give Expression Analysis access to these clients and will allow both companies to expand their service offerings.

“The partnership with Geneblitz® provides us an established presence in the United Kingdom, with an experienced service provider who operates with the same philosophy and similar quality standards and platforms,” stated Steve McPhail, President and CEO of Expression Analysis. Geneblitz® will focus its efforts on Genome-Wide Association studies which have become an increasingly larger part of our business, continued McPhail.

“Expression Analysis is an industry leader with a great reputation in the field of genomic services and our decision to partner with them was not a difficult one,” said Louise Allcroft, Chief Executive Officer of Complement Genomics Ltd. “By combining our experience, scientific leadership and high-throughput capabilities, we will be able to help meet the needs of the extensive pharmaceutical and biotechnology infrastructure in the United Kingdom.”
Advertisement